| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.56 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |